Tag: ACADVL

Comparison of Deeply Versus Mildly Invasive Mesothelioma Proteomes Identifies Potential Links Between Mitochondrial Acadvl Expression and Biomarkers of Aggressiveness[v1]

Preprint Article Version 1 This version is not peer-reviewed Version 1 : Received: 23 May 2023 / Approved: 24 May 2023 / Online: 24 May 2023 (05:06:41 CEST) Pouliquen, D.L.; Kopecka, J.; Blandin, S.; Boissard, A.; Henry, C.; Riganti, C.; Guette, C. Comparison of Deeply Versus Mildly Invasive Mesothelioma Proteomes…

Continue Reading Comparison of Deeply Versus Mildly Invasive Mesothelioma Proteomes Identifies Potential Links Between Mitochondrial Acadvl Expression and Biomarkers of Aggressiveness[v1]

NM_000018.4(ACADVL):c.204G>A (p.Ala68=) AND Very long chain acyl-CoA dehydrogenase deficiency – ClinVar

NM_000018.4(ACADVL):c.204G>A (p.Ala68=) AND Very long chain acyl-CoA dehydrogenase deficiency Based on: 1 submission [Details] Record status: current Accession: RCV001989056.2 Allele description [Variation Report for NM_000018.4(ACADVL):c.204G>A (p.Ala68=)] NM_000018.4(ACADVL):c.204G>A (p.Ala68=) Gene: ACADVL:acyl-CoA dehydrogenase very long chain [Gene – OMIM – HGNC] Variant type: single nucleotide variant Cytogenetic location: 17p13.1 Genomic location: Preferred…

Continue Reading NM_000018.4(ACADVL):c.204G>A (p.Ala68=) AND Very long chain acyl-CoA dehydrogenase deficiency – ClinVar

Hypermethylation of ACADVL is involved in the high-intensity interval training-associated reduction of cardiac fibrosis in heart failure patients

Background: Emerging evidence suggests that DNA methylation can be affected by physical activities and is associated with cardiac fibrosis. This translational research examined the implications of DNA methylation associated with the high-intensity interval training (HIIT) effects on cardiac fibrosis in patients with heart failure (HF). Methods: Twelve HF patients were…

Continue Reading Hypermethylation of ACADVL is involved in the high-intensity interval training-associated reduction of cardiac fibrosis in heart failure patients

MONOCLONAL ANTI-ACADVL | Merck Life Science Indonesia

MONOCLONAL ANTI-ACADVL | Merck Life Science Indonesia The store will not work correctly in the case when cookies are disabled. JavaScript seems to be disabled in your browser. For the best experience on our site,…

Continue Reading MONOCLONAL ANTI-ACADVL | Merck Life Science Indonesia

Table of Pharmacogenomic Biomarkers in Drug Labeling

  Abacavir Infectious Diseases HLA-B Boxed Warning, Dosage and Administration, Contraindications, Warnings and Precautions   Abemaciclib (1) Oncology ESR(Hormone Receptor) Indications and Usage, Adverse Reactions, Clinical Studies   Abemaciclib (2) Oncology ERBB2(HER2) Indications and Usage, Adverse Reactions, Clinical Studies   Abemaciclib (3) Oncology MKI67 Indications and Usage, Dosage and Administration,…

Continue Reading Table of Pharmacogenomic Biomarkers in Drug Labeling

ACADVL – PrimePCR Assay and Template | Life Science

Control assays and synthetic DNA templates were designed to facilitate the assessment of the key experimental factors impacting your real-time PCR results. DNA Contamination Control AssayUse the PrimePCR DNA contamination control assay to determine if genomic DNA (gDNA) is present in a sample at a level that may affect PCR…

Continue Reading ACADVL – PrimePCR Assay and Template | Life Science

Very Long-Chain Acyl-CoA Dehydrogenase Deficiency (ACADVL) Sequencing and Deletion/Duplication

Ordering Recommendation Recommendations when to order or not order the test. May include related or preferred tests. Preferred molecular test to diagnose or rule out very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency following clinical and/or biochemical presentation. May also be used for carrier testing for the reproductive partner of an individual…

Continue Reading Very Long-Chain Acyl-CoA Dehydrogenase Deficiency (ACADVL) Sequencing and Deletion/Duplication

Variant #0000726648 (NC_000017.10:g.7100169G>A, ACADVL(NM_000018.3):c.-23135G>A) – Global Variome shared LOVD

Variant #0000726648 (NC_000017.10:g.7100169G>A, ACADVL(NM_000018.3):c.-23135G>A) Chromosome 17 Allele Unknown Affects function (as reported) Effect unknown Affects function (by curator) Not classified Classification method – Clinical classification VUS DNA change (genomic) (Relative to hg19 / GRCh37) g.7100169G>A DNA change (hg38) – Published as DLG4(NM_001321075.2):c.990C>T (p.G330=) ISCN – DB-ID DLG4_000038 Variant remarks VKGL data sharing initiative Nederland Reference – ClinVar ID – dbSNP ID – Origin CLASSIFICATION record Segregation – Frequency – Re-site –…

Continue Reading Variant #0000726648 (NC_000017.10:g.7100169G>A, ACADVL(NM_000018.3):c.-23135G>A) – Global Variome shared LOVD

Introducing NA by coercion error message when running pathfindR

Since the weekend I’ve been getting an “NAs introduced by coercion” error message when i run the pathfindR package. An example of some of my data is Gene.symbol <- c(“ACAA2”, “ACADVL”, “ACAT1”, “ACOT9”, “ACOX1”, “ADH5”, “AKR1A1”) logFC <- c(“3.3”, “3.9”, “1.5”, “1.7”, “2.4”, “1.9”, “1.7”) adj.P.Val <- c(“0.02”, “0.03”, “0.02”,…

Continue Reading Introducing NA by coercion error message when running pathfindR